ArticleAnnals of African medicine2025
A Retrospective Perspective: Evaluating Pulmonary Embolism Risk Factors and Survival Trends.
Article in Annals of African medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Two decades of pulmonary vascular disease and ischemic heart disease mortality in the united states: A longitudinal analysis using CDC WONDER (1999-2020).Journal of thrombosis and thrombolysis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextPulmonary embolism (PE) is a serious condition that can lead to high rates of illness and death, often affected by different demographic, clinical, and treatment factors. Knowing how these factors work together is important for improving patient care and creating better management plans.
aimsThe goal of this study is to perform a detailed review of patients with a diagnosis of PE, looking into how factors such as age, gender, preexisting health issues, and medical treatments affect survival and disease development. SETTINGS AND
designThis study was carried out in a hospital that provides advanced care, using patient records from individuals diagnosed with PE during a specific timeframe. The study design aimed to find links between demographic, clinical, and treatment factors and their effects on patient outcomes. Data were collected and analyzed systematically to assess trends in survival rates and disease progression in relation to important predictors. SUBJECTS AND
methodsData were gathered from patient records of those diagnosed with PE. Demographic and clinical information was examined to uncover trends linked to higher risks and survival rates. STATISTICAL ANALYSIS USED: The analysis was performed using SPSS/PC software, and Chi-square tests were used to examine differences in demographic features and comorbidities, with a significance level set at P < 0.05.
resultsThe results indicate that age, sex, and the existence of comorbidities have a significant effect on survival rates in patients with PE. Higher mortality was observed in patients over 65, as well as in those with additional cardiovascular and respiratory conditions. Certain treatments were also associated with improved survival rates, highlighting the importance of timely and tailored clinical intervention.
conclusionsThis retrospective study underscores the critical role of demographic and clinical factors in shaping PE outcomes. Age and comorbidities are significant risk factors for mortality in PE patients, while specific treatment approaches correlate with improved survival. These findings support the need for personalized treatment strategies and targeted interventions to enhance patient survival in PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.